JZ
Jason Zemansky BofA Securities Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
11
Avg Return
Past Year
Past Year
28%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Buy
63.6%
Hold
36.4%
Sell
0%
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
Cytokinetics
CYTK
$7.18B
|
Hold
Maintained
| $56 |
7%
downside
| 2 | – |
–
| 2 Oct ‘25 10 days ago |
|
Werewolf Therapeutics
HOWL
$74.5M
|
Buy
Maintained
| $8 |
391%
upside
| 1 | +23% |
0
%
| 25 Aug ‘25 1 month ago |
|
Rocket Pharmaceuticals
RCKT
$369M
|
Buy
Upgraded
| $10 |
192%
upside
| 2 | +21% |
0
%
| 20 Aug ‘25 1 month ago |
|
Insmed
INSM
$34.3B
|
Buy
Maintained
| $109 |
33%
downside
| 2 | +47% |
0
%
| 11 Jun ‘25 4 months ago |
|
Keros Therapeutics
KROS
$638M
|
Hold
Downgraded
| $18 |
15%
upside
| 1 | – |
–
| 10 Jun ‘25 4 months ago |
|
Travere Therapeutics
TVTX
$2.24B
|
Buy
Maintained
| $31 |
23%
upside
| 1 | +40% |
0
%
| 1 Apr ‘25 6 months ago |
|
Arcus Biosciences
RCUS
$1.55B
|
Hold
Maintained
| $17 |
16%
upside
| 1 | – |
–
| 19 Feb ‘25 7 months ago |
|
Kura Oncology
KURA
$855M
|
Buy
Maintained
| $29 |
194%
upside
| 1 | -2.1% |
0
%
| 22 Nov ‘24 10 months ago |
|